Literature DB >> 10435060

No overrepresentation of congenital adrenal hyperplasia in patients with adrenocortical tumours.

M Kjellman1, M Holst, M Bäckdahl, C Larsson, L O Farnebo, A Wedell.   

Abstract

OBJECTIVE: The development and progression of sporadic adrenocortical tumours are poorly understood. In autopsy studies adrenocortical tumours are found in between 2 and 9% of the general population. In congenital adrenal hyperplasia (CAH), decreased production of cortisol leads to increased secretion of ACTH from the pituitary, resulting in hyperplasia of the adrenals. More than 95% of all cases of CAH are due to steroid 21-hydroxylase deficiency, resulting from mutations in the CYP21 gene. In subjects homozygous and heterozygous for CYP21 mutations, adrenocortical tumours have been found in a high frequency compared to the general population, suggesting that chronic ACTH stimulation may play a role in the development of this tumour form. In order to test whether mild undiagnosed CAH is a common predisposing factor, we screened 27 patients with sporadic adrenocortical tumours for CYP21 mutations.
DESIGN: A retrospective study. PATIENTS: We screened 27 patients with sporadic adrenocortical tumours, representing both benign and malignant as well as hormonally active and silent lesions. MEASUREMENTS: Mutation analyses of the CYP21 gene was performed by allele-specific PCR on high molecular weight DNA. The method used detects the nine CYP21 mutations that are responsible for 95% of all disease-causing alleles in CAH.
RESULTS: No mutations were detected in any of the 23 DNA samples that were prepared from leucocytes. In 4 cases where no leucocyte DNA was available, tumour tissue was analysed. In one of these tumours, two CYP21 mutations, V281 L and L307insT, were found in heterozygous form.
CONCLUSION: Our data indicate that mild undiagnosed congenital adrenal hyperplasia is not a common underlying factor predisposing to adrenocortical tumours, at least not in the Swedish population.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10435060     DOI: 10.1046/j.1365-2265.1999.00655.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  5 in total

Review 1.  Genetic background of adrenocortical tumor development.

Authors:  M Kjellman; C Larsson; M Bäckdahl
Journal:  World J Surg       Date:  2001-07       Impact factor: 3.352

2.  An 88-year-old woman diagnosed with adrenal tumor and congenital adrenal hyperplasia: connection or coincidence?

Authors:  H Falhammar; M Thorén
Journal:  J Endocrinol Invest       Date:  2005-05       Impact factor: 4.256

Review 3.  The role of 21-hydroxylase in the pathogenesis of adrenal masses: review of the literature and focus on our own experience.

Authors:  L Barzon; P Maffei; N Sonino; C Pilon; L Baldazzi; A Balsamo; O Del Maschio; G Masi; M Trevisan; M Pacenti; F Fallo
Journal:  J Endocrinol Invest       Date:  2007 Jul-Aug       Impact factor: 4.256

4.  Bilateral adrenal incidentalomas: a case report and review of diagnostic challenges.

Authors:  Anders L Carlson; Annis M Marney; Scott R Anderson; Matthew P Gilbert
Journal:  Case Rep Endocrinol       Date:  2013-01-17

5.  Two adults with adrenal myelolipoma and 21-hydroxylase deficiency.

Authors:  Ingrid Nermoen; Ivar Følling; Kjetil Vegge; Arne Larmo; Bjørn Gunnar Nedrebø; Eystein Sverre Husebye; Kristian Løvås
Journal:  Case Rep Med       Date:  2009-08-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.